Description: Phosphagenics Limited, a research-based biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. The company operates through Production and Personal Care, and Human Health segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It serves customers in Australia, Switzerland, the United States, India, Japan, China, and internationally. The company was formerly known as Vital Capital Limited and changed its name to Phosphagenics Limited in 2004. Phosphagenics Limited is headquartered in Melbourne, Australia.
Exchange: STU
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Metals & Mining |
| GIC Sub-Industry: | Diversified Metals & Mining |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.2336 |
| Price-to-Sales TTM: | 9.5059 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |